Corticosteroids + Cyclosporine + mycophenolate mofetil

Phase 2Terminated
0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pediatric Liver Transplantation

Conditions

Pediatric Liver Transplantation

Trial Timeline

May 1, 2003 → Jan 1, 2005

About Corticosteroids + Cyclosporine + mycophenolate mofetil

Corticosteroids + Cyclosporine + mycophenolate mofetil is a phase 2 stage product being developed by Roche for Pediatric Liver Transplantation. The current trial status is terminated. This product is registered under clinical trial identifier NCT02630563. Target conditions include Pediatric Liver Transplantation.

What happened to similar drugs?

3 of 19 similar drugs in Pediatric Liver Transplantation were approved

Approved (3) Terminated (0) Active (16)

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02630563Phase 2Terminated